Published in Heart Fail Rev on September 01, 2012
Burden of Comorbidities and Functional and Cognitive Impairments in Elderly Patients at the Initial Diagnosis of Heart Failure and Their Impact on Total Mortality: The Cardiovascular Health Study. JACC Heart Fail (2015) 2.84
Aging of the United States population: impact on heart failure. Curr Heart Fail Rep (2012) 1.00
Hand osteoarthritis in relation to mortality and incidence of cardiovascular disease: data from the Framingham heart study. Ann Rheum Dis (2013) 0.96
Exercise training as therapy for heart failure: current status and future directions. Circ Heart Fail (2015) 0.95
Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem. J Geriatr Cardiol (2015) 0.95
Frailty and risk for heart failure in older adults: the health, aging, and body composition study. Am Heart J (2013) 0.94
Is frailty associated with short-term outcomes for elderly patients with acute coronary syndrome? J Geriatr Cardiol (2015) 0.85
The relationship between measures of obesity and incident heart failure: the multi-ethnic study of atherosclerosis. Obesity (Silver Spring) (2013) 0.85
Epidemiology of heart failure with preserved ejection fraction. Heart Fail Clin (2014) 0.83
Peripheral arterial disease and chronic heart failure: a dangerous mix. Heart Fail Rev (2013) 0.83
Frailty syndrome and self-care ability in elderly patients with heart failure. Clin Interv Aging (2015) 0.82
Comorbidity profiles and inpatient outcomes during hospitalization for heart failure: an analysis of the U.S. Nationwide inpatient sample. BMC Cardiovasc Disord (2014) 0.82
Frailty in advanced heart failure: a systematic review. Heart Fail Rev (2015) 0.80
Heart failure in elderly: progress in clinical evaluation and therapeutic approach. J Geriatr Cardiol (2013) 0.80
Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc (2016) 0.79
Left ventricle diastolic dysfunction and prognosis. Circulation (2012) 0.79
Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study. Pharmgenomics Pers Med (2016) 0.75
Prognostic Importance of Dyspnea for Cardiovascular Outcomes and Mortality in Persons without Prevalent Cardiopulmonary Disease: The Atherosclerosis Risk in Communities Study. PLoS One (2016) 0.75
Heart failure with a normal ejection fraction: treatments for a complex syndrome? Curr Treat Options Cardiovasc Med (2012) 0.75
Contribution of the long-term care insurance certificate for predicting 1-year all-cause readmission compared with validated risk scores in elderly patients with heart failure. Open Heart (2016) 0.75
Potentially inappropriate medications use in community-based aged patients: a cross-sectional study using 2012 Beers criteria. Clin Interv Aging (2017) 0.75
Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale. Am Heart J (2016) 0.75
Submaximal oxygen uptake kinetics, functional mobility, and physical activity in older adults with heart failure and reduced ejection fraction. J Geriatr Cardiol (2016) 0.75
Heart Failure Among Older Adults in Skilled Nursing Facilities: More of a Dilemma Than Many Now Realize. Curr Geriatr Rep (2015) 0.75
Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci (2001) 42.21
Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med (2009) 35.68
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13
Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med (2002) 16.98
Telemonitoring in patients with heart failure. N Engl J Med (2010) 10.82
Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37
Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med (2008) 9.62
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet (2003) 8.12
Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc (2005) 6.73
The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation (2006) 6.58
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med (1997) 5.93
Cachexia: a new definition. Clin Nutr (2008) 5.49
Medication adherence: its importance in cardiovascular outcomes. Circulation (2009) 5.30
Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci (2001) 5.09
Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med (2002) 4.97
Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol (2003) 4.57
Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ (2003) 4.24
Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA (2002) 4.06
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet (2005) 3.67
Wasting as independent risk factor for mortality in chronic heart failure. Lancet (1997) 3.37
Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J (2007) 2.76
Inflammation and frailty in older women. J Am Geriatr Soc (2007) 2.66
Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol (2010) 2.43
The effect of randomization to weight loss on total mortality in older overweight and obese adults: the ADAPT Study. J Gerontol A Biol Sci Med Sci (2010) 2.12
Assessing the impact of comorbidity in the older population. Ann Epidemiol (1996) 1.74
Frailty predicts long-term mortality in elderly subjects with chronic heart failure. Eur J Clin Invest (2005) 1.68
Cardiac cachexia: a systematic overview. Pharmacol Ther (2008) 1.49
The obesity paradox: fact or fiction? Am J Cardiol (2006) 1.41
Frailty and its association with disability and comorbidity in a community-dwelling sample of seniors in Montreal: a cross-sectional study. Aging Clin Exp Res (2009) 1.29
Frailty. Med Clin North Am (2006) 1.25
Age disparities in heart failure research. JAMA (2010) 1.23
Vitamin D deficiency and frailty in older Americans. J Intern Med (2010) 1.23
The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc (2008) 1.23
Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail (2011) 1.22
Predictors of early readmission or death in elderly patients with heart failure. Am Heart J (2010) 1.18
Anorexia, sarcopenia, and aging. Nutrition (2001) 1.17
A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility. Circ Heart Fail (2010) 1.15
Frailty and chronic diseases in older adults. Clin Geriatr Med (2011) 1.10
Aging and heart failure: changing demographics and implications for therapy in the elderly. Heart Fail Rev (2010) 1.10
The challenges of clinical trials in the exclusion zone: the case of the frail elderly. Australas J Ageing (2008) 1.06
Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study. J Cardiovasc Med (Hagerstown) (2010) 1.03
Frequent non-cardiac comorbidities in patients with chronic heart failure. Eur J Heart Fail (2005) 0.98
Frailty and impaired cardiac autonomic control: new insights from principal components aggregation of traditional heart rate variability indices. J Gerontol A Biol Sci Med Sci (2009) 0.94
The role of prognostic stratification in preventing the bias permitted by random allocation of treatment. J Chronic Dis (1976) 0.85
Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients. Heart (1997) 0.85
Causes and consequences of nonpersistence with heart failure medication. Am J Cardiol (2009) 0.77
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation (2006) 3.40
The amyloidogenic V122I transthyretin variant in elderly black Americans. N Engl J Med (2015) 3.36
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J (2007) 3.34
The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure. J Card Fail (2005) 3.26
Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol (2011) 3.19
Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med (2002) 3.17
6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. J Am Coll Cardiol (2012) 3.03
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 2.83
Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study. Hypertension (2004) 2.36
Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study. J Am Coll Cardiol (2007) 2.30
Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model. Circ Heart Fail (2011) 2.28
American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr (2008) 2.25
Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. J Am Coll Cardiol (2004) 2.17
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J (2011) 2.14
The effect of randomization to weight loss on total mortality in older overweight and obese adults: the ADAPT Study. J Gerontol A Biol Sci Med Sci (2010) 2.12
Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients. J Cardiopulm Rehabil (2006) 2.10
Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis. Am Heart J (2006) 2.10
Congestive heart failure incidence and prognosis: case identification using central adjudication versus hospital discharge diagnoses. Ann Epidemiol (2005) 2.03
Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. J Gerontol A Biol Sci Med Sci (2009) 2.02
Survival associated with two sets of diagnostic criteria for congestive heart failure. Am J Epidemiol (2004) 1.99
Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons > or =65 years of age (the cardiovascular health study). Am J Cardiol (2005) 1.82
Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing). Am J Cardiol (2008) 1.79
EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation (2012) 1.67
Abdominal obesity is an independent risk factor for chronic heart failure in older people. J Am Geriatr Soc (2006) 1.63
Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. J Am Coll Cardiol (2012) 1.59
Endurance exercise training in older patients with heart failure: results from a randomized, controlled, single-blind trial. J Am Geriatr Soc (2009) 1.54
The effect of intentional weight loss on all-cause mortality in older adults: results of a randomized controlled weight-loss trial. Am J Clin Nutr (2011) 1.54
Chronotropic incompetence: causes, consequences, and management. Circulation (2011) 1.54
The relationship of a 6-min walk to VO(2 peak) and VT in older heart failure patients. Med Sci Sports Exerc (2006) 1.51
Aortic valve sclerosis is associated with preclinical cardiovascular disease in hypertensive adults: the Hypertension Genetic Epidemiology Network study. J Hypertens (2005) 1.49
Assessment of the interaction of heritability of volume load and left ventricular mass: the HyperGEN offspring study. J Hypertens (2007) 1.46
Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study. Circ Heart Fail (2011) 1.45
Costs for heart failure with normal vs reduced ejection fraction. Arch Intern Med (2006) 1.36
The association of alcohol consumption and incident heart failure: the Cardiovascular Health Study. J Am Coll Cardiol (2006) 1.35
Relation of aortic distensibility determined by magnetic resonance imaging in patients > or =60 years of age to systolic heart failure and exercise capacity. Am J Cardiol (2002) 1.32
Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health Study. Am Heart J (2007) 1.29
Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction. Am J Cardiol (2005) 1.28
Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study. J Hypertens (2002) 1.27
Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass. J Gerontol A Biol Sci Med Sci (2013) 1.27
Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Heart Fail (2012) 1.27
Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study. Circ Heart Fail (2009) 1.27
Leg flow-mediated arterial dilation in elderly patients with heart failure and normal left ventricular ejection fraction. Am J Physiol Heart Circ Physiol (2006) 1.24
Application of assessing care of vulnerable elders-3 quality indicators to patients with advanced dementia and poor prognosis. J Am Geriatr Soc (2007) 1.22
Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail (2011) 1.22
Relation between volume of exercise and clinical outcomes in patients with heart failure. J Am Coll Cardiol (2012) 1.20
Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study. Eur Heart J (2004) 1.15
Relationship of flow-mediated arterial dilation and exercise capacity in older patients with heart failure and preserved ejection fraction. J Gerontol A Biol Sci Med Sci (2012) 1.14
Growth hormone replacement attenuates diastolic dysfunction and cardiac angiotensin II expression in senescent rats. J Gerontol A Biol Sci Med Sci (2006) 1.13
Patterns of weight change associated with long-term weight change and cardiovascular disease risk factors in the Look AHEAD Study. Obesity (Silver Spring) (2012) 1.12
Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: the HF-ACTION study. Am Heart J (2009) 1.11
Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study. Eur J Heart Fail (2012) 1.07
Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes. Circ Heart Fail (2013) 1.07
Appropriateness of quality indicators for older patients with advanced dementia and poor prognosis. J Am Geriatr Soc (2003) 1.04
Progressive diastolic dysfunction in the female mRen(2). Lewis rat: influence of salt and ovarian hormones. J Gerontol A Biol Sci Med Sci (2008) 1.03
Method for establishing authorship in a multicenter clinical trial. Ann Intern Med (2009) 1.02
Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circulation (2013) 1.02
Third pivotal research in cardiology in the elderly (PRICE-III) symposium: heart failure in the elderly: mechanisms and management. Am J Geriatr Cardiol (2005) 1.01
Lifestyle intervention improves heart rate recovery from exercise in adults with type 2 diabetes: results from the Look AHEAD study. J Obes (2012) 1.01
Effect of losartan and hydrochlorothiazide on exercise tolerance in exertional hypertension and left ventricular diastolic dysfunction. Am J Cardiol (2006) 1.00
Reliability of peak exercise testing in patients with heart failure with preserved ejection fraction. Am J Cardiol (2012) 1.00
The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the Cardiovascular Health Study. Circ Heart Fail (2011) 0.99
EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J (2012) 0.99
Heart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) study. JACC Heart Fail (2013) 0.95
Relationship of physical function to vastus lateralis capillary density and metabolic enzyme activity in elderly men and women. Aging Clin Exp Res (2008) 0.95
Genome-wide linkage mapping for valve calcification susceptibility loci in hypertensive sibships: the Hypertension Genetic Epidemiology Network Study. Hypertension (2007) 0.95
VE/VCO2 slope in older heart failure patients with normal versus reduced ejection fraction compared with age-matched healthy controls. J Card Fail (2007) 0.95
The Arg16Gly polymorphism of the beta2-adrenergic receptor and left ventricular systolic function. Am J Hypertens (2003) 0.94
Effect of candesartan and verapamil on exercise tolerance in diastolic dysfunction. J Cardiovasc Pharmacol (2004) 0.94
Exercise training in heart failure with preserved ejection fraction: beyond proof-of-concept. J Am Coll Cardiol (2011) 0.94
Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical function in healthy older adults. J Gerontol A Biol Sci Med Sci (2012) 0.94
Effect of aldosterone antagonism on exercise tolerance, Doppler diastolic function, and quality of life in older women with diastolic heart failure. Congest Heart Fail (2009) 0.94
Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail (2012) 0.94
A whole genome scan for pulse pressure/stroke volume ratio in African Americans: the HyperGEN study. Am J Hypertens (2007) 0.93
Aging and physical mobility in group-housed Old World monkeys. Age (Dordr) (2011) 0.92
Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction. Am J Med (2013) 0.92
Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress. J Cardiovasc Magn Reson (2009) 0.91
The restoration of chronotropic competence in heart failure patients with normal ejection fraction (RESET) study: rationale and design. J Card Fail (2009) 0.91
Associations of aortic and mitral regurgitation with body composition and myocardial energy expenditure in adults with hypertension: the Hypertension Genetic Epidemiology Network study. Am Heart J (2003) 0.91
Linkage of left ventricular early diastolic peak filling velocity to chromosome 5 in hypertensive African Americans: the HyperGEN echocardiography study. Am J Hypertens (2002) 0.91
Reduced peripheral arterial blood flow with preserved cardiac output during submaximal bicycle exercise in elderly heart failure. J Cardiovasc Magn Reson (2009) 0.90
Transthyretin V122I in African Americans with congestive heart failure. J Am Coll Cardiol (2006) 0.90
Gender difference in diastolic function in hypertension (the HyperGEN study). Am J Cardiol (2002) 0.90
Hospitalizations due to unstable angina pectoris in diastolic and systolic heart failure. Am J Cardiol (2006) 0.88
Body composition and fat distribution influence systemic hemodynamics in the absence of obesity: the HyperGEN Study. Am J Clin Nutr (2005) 0.87
Exercise training improves heart rate variability in older patients with heart failure: a randomized, controlled, single-blinded trial. Congest Heart Fail (2012) 0.87
Left atrial systolic force and cardiac markers of preclinical disease in hypertensive patients: the Hypertension Genetic Epidemiology Network (HyperGEN) Study. Am J Hypertens (2005) 0.87
Sibling resemblance for left ventricular structure, contractility, and diastolic filling. Hypertension (2002) 0.87
Prevalence and management of chronotropic incompetence in heart failure. Curr Cardiol Rep (2007) 0.87
Diastolic function: a barometer for cardiovascular risk? Anesthesiology (2010) 0.87
Understanding results of trials in heart failure with preserved ejection fraction: remembering forgotten lessons and enduring principles. J Am Coll Cardiol (2011) 0.86
Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving β-blocker therapy: data from the HF-ACTION trial. Eur Heart J (2013) 0.86
Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study. Am J Hypertens (2004) 0.86
Relation of insulin to left ventricular geometry and function in African American and white hypertensive adults: the HyperGEN study. Am J Hypertens (2002) 0.85
Imagent improves endocardial border delineation, inter-reader agreement, and the accuracy of segmental wall motion assessment. Echocardiography (2003) 0.85
Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events. Int J Cardiol (2013) 0.84
Decreased left ventricular distensibility in response to postural change in older patients with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol (2010) 0.84
Cardiopulmonary exercise testing is equally prognostic in young, middle-aged and older individuals diagnosed with heart failure. Int J Cardiol (2010) 0.83
Outcomes in patients with heart failure with preserved ejection fraction: it is more than the heart. J Am Coll Cardiol (2012) 0.83